Medical therapy currently assumes that all individuals with a given condition should be treated in the same way, guided by empirical evidence from clinical trials. This ignores interindividual differences, which may predict variable therapeutic efficacy or adverse drug reactions. Considerable evidence suggests that genetic makeup determines much of this variability, and major efforts are being made to harness genetics to predict drug responses. Pharmacogenetics can improve the power and infor...Expand abstract
- Dialogues in Cardiovascular Medicine
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date:
Should genetic testing become a standard component of clinical trials in order to advance evidence-based cardiology practice?
If you are the owner of this record, you can report an update to it here: Report update to this record